The xenograft transplantation assays showed BCL11B KO LoVo cells exhibited impaired tumor development, with a reduction of both tumor weight and tumor size, compared to parental cells (Fig. 6G; Appendix Fig. S7H). This evidence concerns the gene BCL11B and neoplasm.